Laboratoire Aguettant S.A.S.

International Private company
BP 7144, Parc Scientifique Garnier, 1 rue Alexander Fleming, Lyon,  F-69353 Cedex 07, France
()33 04 78 61 51 41, 33 04 78 61 09 35 fax, http://www.aguettant.fr

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture of injectable medication

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Laboratoire Aguettant S.A.S., News and Information

Cephalon Announces 1997 Financial Results
PR Newswire; 2/24/1998; 1458 words; ...company's license agreement with Laboratoire L. Lafon to develop and market...bulk modafinil inventory from Laboratoire L. Lafon during the 1997 second...expenses of $2.1 million to Laboratoire Aguettant S.A. for acquisition of rights...

Cephalon To Promote Apokinon(R) for Aguettant in France
PR Newswire; 1/29/1998; 961 words; ...ten-year agreement with Laboratoire Aguettant S.A. to promote and market...or Gregoire Barrowcliff of Laboratoire Aguettant S.A., 011-33-1-78...Cephalon U.K., Ltd.; Laboratoire Aguettant S.A. ST: Pennsylvania IN...

EMPI COMPLETES ACQUISITION OF BIOFEEDBACK COMPANY
PR Newswire; 8/13/1993; 1134 words; ...and treatment with Empi's INNOVA Feminine Incontinence...measurement device. All of PHD's EMG biofeedback products...as division director for Laboratoire Aguettant, a French intravenous drug...continue development of Empi's proprietary reflex testing...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.